Bigul

Fermenta Biotech Ltd - 506414 - Execution Of Sale Deed

Further to our earlier intimation dated June 9, 2022 in relation to the members' approval obtained to sell, lease, or otherwise dispose of the portion of Company's assets being premises located in Thane One Building, DIL Complex, Ghodbunder Road, Majiwade, Thane (West) 400 610, we wish to inform you that the Company has executed and registered a sale deed on May 16, 2023 to sell premises situated at the 10th floor in Thane One Building, DIL Complex, Ghodbunder Road, Majiwade, Thane (West) 400 610 on the terms and conditions mentioned in the sale deed and as approved by the Board of Directors of the Company. The information regarding the aforesaid sale of premises is provided in Annex-'A' herewith.
17-05-2023
Bigul

Fermenta Biotech Ltd - 506414 - Execution Of Sale Deed

Further to our earlier intimation dated June 9, 2022 in relation to the members' approval obtained to sell, lease, or otherwise dispose of the portion of Company's assets being premises located in Thane One Building, DIL Complex, Ghodbunder Road, Majiwade, Thane (West) 400 610, we wish to inform you that the Company has executed and registered a sale deed on May 15, 2023 to sell premises situated at the 4th floor in Thane One Building, DIL Complex, Ghodbunder Road, Majiwade, Thane (West) 400 610 on the terms and conditions mentioned in the sale deed and as approved by the Board of Directors of the Company. The information regarding the aforesaid sale of premises is provided in Annex-'A' herewith. This intimation is given under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 for your records.
15-05-2023
Bigul

Fermenta Biotech Ltd - 506414 - Approval Of The Composite Scheme Of Amalgamation And Arrangement Amongst DVK Investments Private Limited ('Transferor Company 1') And Aegean Properties Limited ('Transferor Company 2') And Fermenta Biotech Limited ('Transferee Company') And Their Respective Shareholders, Under Sections 230 To 232 Of The Companies Act, 2013 ('Scheme') By The Hon'Ble National Company Law Tribunal, Mumbai Bench

With reference to the captioned subject, we would like to inform you that the National Company Law Tribunal, Mumbai Bench ('NCLT') has approved the Composite Scheme of Amalgamation and Arrangement amongst DVK Investments Private Limited ('Transferor Company 1') and Aegean Properties Limited ('Transferor Company 2') and Fermenta Biotech Limited ('Transferee Company') and their respective Shareholders on 08th May 2023 and the order copy was uploaded on NCLT website on 09th May 2023. The certified copy of order is awaited. The Scheme shall become effective upon filing certified copy of the order along with the Scheme with the Registrar of Companies, Mumbai. We request you to kindly take the above information on record.
09-05-2023
Bigul

Fermenta Biotech Ltd - 506414 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyFermenta Biotech Ltd 2CIN NO.L99999MH1951PLC008485 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 115.32 4Highest Credit Rating during the previous FY BBB+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. YES Name of the Company Secretary: Srikant Sharma Designation: Company Secretary EmailId: srikant.sharma@fermentabiotech.com Name of the Chief Financial Officer: Sumesh Gandhi Designation: Chief Financial Officer EmailId: sumesh.gandhi@fermentabiotech.com Date: 30/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
30-04-2023
Bigul

Fermenta Biotech Ltd - 506414 - Execution Of Sale Deed

Further to our earlier intimation dated June 9, 2022 in relation to the members' approval obtained to sell, lease, or otherwise dispose of the portion of Company's assets being premises located in Thane One Building, DIL Complex, Ghodbunder Road, Majiwade, Thane (West) 400 610, we wish to inform you that the Company has executed and registered a sale deed on April 26, 2023 to sell premises situated at the 6th floor in Thane One Building, DIL Complex, Ghodbunder Road, Majiwade, Thane (West) 400 610 on the terms and conditions mentioned in the sale deed and as approved by the Board of Directors of the Company. The information regarding the aforesaid sale of premises is provided in Annex-'A' herewith. This intimation is given under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 for your records.
26-04-2023
Bigul

Fermenta Biotech Ltd - 506414 - Compliance Certificate Under Regulation 40(9) Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 40(9) of the Listing Regulations, we are enclosing Certificate dated April 14, 2023 issued by M/s V. N. Deodhar & Co., Company Secretaries, for the period April 1, 2022 to March 31, 2023. Kindly take the above on record.
21-04-2023
Bigul

Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received information from the shareholder about loss of share certificates on April 21, 2023
21-04-2023
Bigul

Fermenta Biotech Ltd - 506414 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Pursuant to the provisions of Regulation 74(5) of SEBI (Depositories and Participants), Regulations 2018, for the quarter ended March 31, 2023, we hereby certify that on receipt of securities for dematerialization - a. The securities comprised in the said certificate(s) of security have been listed on the stock exchanges where the earlier securities are listed; b. The said certificate(s) after due verification have been mutilated and cancelled and the name of the depositories have been substituted in the register of members as the registered owner.
20-04-2023
Bigul

Fermenta Biotech Ltd - 506414 - Compliance Certificate - Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Period April 1, 2022 To March 31, 2023

As per the requirement of Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained during the period April 1, 2022 to March 31, 2023 (both days inclusive) by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited, which is registered as Registrar & Share Transfer Agent in Category-I with the Securities and Exchange Board of India vide Registration Number: INR000004058.
17-04-2023
Bigul

Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received information from the shareholder about loss of share certificates on April 11, 2023.
11-04-2023
Next Page
Close

Let's Open Free Demat Account